Catheter Precision (VTAK) Proxy filing summary

Executive summary

• Special Meeting scheduled for April 15, 2026, to vote on six key proposals impacting capital structure and corporate governance.

• Proposals include authorizations for new share issuances, a reverse stock split, and potential adjournment to solicit additional votes.

• Board recommends voting in favor of all proposals, citing strategic financing needs and compliance with NYSE American rules.

• Forward-looking statements highlight risks related to financing, dilution, and market impacts.

Voting matters and shareholder proposals

• Proposal 1: Approve issuance of common stock underlying Series C Preferred Stock, potentially exceeding 19.99% of pre-issuance shares.

• Proposal 2: Approve issuance of common stock underlying Series D Preferred Stock, related to the acquisition of FLYTE and Ponderosa Air.

• Proposal 3: Approve issuance of common stock underlying Series J Preferred Stock, issued to settle royalty rights with insiders.

• Proposal 4: Approve issuance of additional shares due to reduced conversion price of Series B Preferred Stock.

• Proposal 5: Approve a reverse stock split at a ratio between 1-for-2 and 1-for-100, at Board discretion.

• Proposal 6: Approve adjournment or postponement of the meeting to solicit more votes if needed.

Board of directors and corporate governance

• Board unanimously recommends voting "FOR" all proposals.

• Independent directors approved insider-related transactions, with interested parties abstaining.

• Board retains discretion on timing and ratio of reverse stock split.